Patent fees in the Eurasian Patent Organization will be increased starting from 1 February 2025

1 неделя ago
pat

The Eurasian Patent Organization will be raising the fees for several services starting from February 1, 2025. This adjustment is…

At the end of 2024

1 месяц ago

At the end of 2024, as the year comes to a close, it is time to reflect on the past…

The benefits of the Eurasian patent system: a single patent for multiple countries

2 месяца ago

In 1995, the Eurasian Patent Convention (EAPC) was established to create a unified patent space, simplifying and reducing the cost…

Patentica at APAA 2024

2 месяца ago

Olga Gribanova and Eduard Shablin of Patentica were in attendance at the 76th Asian Patent Attorneys Association Council Meeting (APAA…

Tracking deadlines is an essential aspect of patent prosecution

2 месяца ago

Dear colleagues, we would like to inform you about the weekends and holidays in 2025 that will impact the workflow…

October 24-26, 2024 | Patentica took part in AIPLA 2024 Annual Meeting

3 месяца ago

Maria Nilova and Nikolai Kovkov from Patentica recently participated in the AIPLA 2024 Annual Meeting at the Gaylord National Resort…

Patentica participated in the LES USA-Canada Annual Meeting | October 20-23, 2024

3 месяца ago

Maria Nilova and Nikolai Kovkov from Patentica recently took part in the LES USA-Canada Annual Meeting from October 20 to…

4,667 intellectual property infringements were identified in the EAEU in 2023

3 месяца ago

On October 9, a meeting of the Advisory Committee on Intellectual Property under the Board of the Eurasian Economic Commission…

Rospatent’s clarifications on the Statute on Fees as amended

4 месяца ago

The Russian Patent and Trademark Office has issued clarifications regarding some typical questions on the new Statute on Fees, effective…

Revocation of Patent RU 2421238 Related to Liraglutide Composition (Sun Pharmaceuticals Industries, Ltd (IN) v. Novo Nordisk A/S (DK))

4 месяца ago

Patentica’s patent attorneys, Victor Lisovenko and Ksenia Emelianova have successfully represented Sun Pharmaceuticals in opposing Novo Nordisk’s patent RU 2421238.…